Methodology for assessing drug-drug interaction evidence in the peer-reviewed medical literature

Current Therapeutic Research - Clinical and Experimental

Volumn 61, Issue 8, 2000, Pages 553-568

  Valuck, Robert J ^a   Byrns, Patricia J ^b   Fulda, Thomas R ^c   Zanden, Jeanne Vander ^d   Parker, Sandra ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c UNITED STATES PHARMACOPEIA   (United States)

^d JVZ Consulting   (United States)

Author keywords

Drug information; Drug utilization review; Drug drug interactions; Evidence based medicine

Indexed keywords

DRUG;

ARTICLE; DRUG INFORMATION; EVIDENCE BASED MEDICINE; MEDICAL INFORMATION; MEDICAL LITERATURE; PEER REVIEW; PRIORITY JOURNAL; PUBLICATION;

EID: 0033847833     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(00)80038-7     Document Type: Article

References (61)

1. Disagreement among drug compendia on inclusion and ratings of drug-drug interactions
2. Computer-based drug-utilization review: Risk, benefit, or boondoggle?
3. Drug utilization review in ambulatory settings: State of the science and directions for outcomes research
4. Opening the black box: A case study of conflicting review criteria
5. A congressional perspective on inappropriate drug therapy and drug utilization review
6. Inappropriate drug therapy and drug use review: An annotated bibliography for state policymakers
7. Drug-utilization review: Moving toward an effective and safe model
8. When warnings are not enough: Primary prevention through drug use review
9. How pharmacists respond to on-line, real-time, DUR alerts
10. Users guides to the medical literature. I. How to get started
11. Adverse drug events and the freedom of information act: An apple in Eden
12. Searching for information on toxicological data of chemical substances in selected bibliographic databases-selection of essential databases for toxicological researches
13. Cadeuceus: EMBASE update for the pharmaceutical searcher
14. The comprehensiveness of Medline and Embase computer searches
15. Comparison and evaluation of nine bibliographic databases concerning adverse drug reactions
16. Crossover comparison of drug information online database vendors: Dialog and Medlars
17. Evaluation of drug interaction document citation in nine on-line bibliographic databases
18. Where should the pharmacy researcher look first? Comparing International Pharmaceutical Abstracts and MEDLINE
19. Identifying relevant studies for systematic reviews
20. The application of quality filters in searching the clinical literature: Some possible heuristics
21. Quantitative comparison of pre-explosions and subheading with methodologic search terms in MEDLINE
22. The art and science of searching MEDLINE to answer clinical questions: Finding the right number of articles
23. How easy are randomized controlled trials in epilepsy to find on Medline? The sensitivity and precision of two Medline searches
24. Developing optimal search strategies for detecting clinically sound studies in MEDLINE
25. Assessment of methodologic search filters in MEDLINE
26. Collecting the evidence systematically: Ensuring that it is complete and up-to-date
27. Methods used by pharmacy departments to identify drug interactions
28. How good are clinical MEDLINE searches? A comparative study of clinical end-user and librarian searches
29. The scientific basis of drug-drug interactions: Mechanism and preclinical evaluation
30. In vitro metabolic interaction studies: Experience of the Food and Drug Administration
31. Instruments for assessing the quality of drug studies published in the medical literature
32. Systems to evaluate published data
33. Systematic reviews-theory and practice
34. Developing evidence-based clinical practice guidelines: Lessons learned by the US Preventive Services Task Force
35. Systematic reviews: Synthesis of best evidence for clinical decisions
36. Understanding and evaluating clinical trials
37. Meta-analyses to evaluate analgesic interventions: A systematic qualitative review of their methodology
38. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
39. Assessing the quality of randomized controlled trials: Current issues and future directions
40. Perioperative parenteral nutrition: A meta-analysis
41. Agreement among reviewers of review articles
42. The quality of drug studies published in symposium proceedings
43. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis
44. Invited commentary: A critical look at some popular meta-analytic methods
45. The hazards of scoring the quality of clinical trials for meta-analysis
46. An algorithm for the operational assessment of adverse drug reactions. I. Background, description and instructions for use
47. Causality assessment of adverse reactions to drugs. I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
48. A method for estimating the probability of adverse drug reactions
49. Comparison of 500 spontaneous and 500 published reports of adverse drug reactions
50. International reporting on adverse drug reactions: The CIOMS project. CIOMS ADR Working Group
51. Updating of a method for causality assessment of adverse drug reactions
52. Medicaid drug utilization review: A critical appraisal
53. Frequency, severity and risk factors for adverse drug reactions in adult outpatients: A prospective study
54. Assessing the quality of randomized trials: Reliability of the Jadad scale
55. Measuring the quality of trials: The quality of quality scales
56. Implementing an effective drug interaction reporting program